Dr. ?ric A. Cohen, a researcher at the IRCM (Institut de recherches cliniques de Montr?al), and his team will publish on Friday, July 13, in PLoS Pathogens a discovery that could lead to the development of a new class of drugs to combat HIV.
A clinical trial involving 5,045 women in South Africa and Zimbabwe found no statistical difference in the rate of new HIV infections in the two study arms: those who received a diaphragm plus lubricant along with male condoms for their partners, and those who only received male condoms.
A UCSF-led team of researchers has found that larger HIV prevention programs in low and middle-income countries can increase efficiency and cause program unit costs to plummet. HIV prevention programs in Uganda, South Africa, Mexico, Russia and India were examined.
The World Bank today said it will lend 250 million dollars to India for supporting the National AIDS Control Programme over the next five years.
Researchers from the University of Granada and Hospital Carlos III in Madrid, verified that maslinic acid — found in wax from olive skin — inhibits serin-protease, the enzyme used by HIV to release itself from the infected cell into the extracellular environment.
Nearly half of all people infected with HIV/AIDS are now women, the majority of whom contracted the disease through sexual intercourse with male partners.
Indian cinemagoers will soon see short films by India’s top directors about the impact of HIV/AIDS, which will be screened ahead of Bollywood movie blockbusters, reported by PTI.
Indian government put the figure of people suffering from HIV/AIDS in the country at 2.5 million, a drastic reduction of around 50 per cent from last year.
Results from a Phase 3 head-to-head study showed that a significantly greater percent (77 percent) of treatment-experienced HIV-1 infected adults* taking Prezista? (darunavir)/ritonavir, with an optimised background regimen (OBR) of antiretroviral agents, reached a viral load of less than 400 copies/mL at week 48, compared to 68 percent of patients taking the widely prescribed medication lopinavir/ritonavir, with OBR, in a per-protocol analysis (95 percent confidence interval 2-16). In addition, significantly more patients receiving darunavir/r in this study reached an undetectable viral load (<50 copies/mL) compared to patients taking lopinavir/r (71 percent vs. 60 percent).
United Nations Deputy Secretary-General Asha-Rose Migiro today called for a more broad-based effort to tackle the impact of HIV/AIDS on women and girls.